Expert Hepatology & Infectious Disease Care at Ruijin Hospital
The Department of Infectious Diseases and Hepatology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is one of China's leading centers for the diagnosis and treatment of viral hepatitis, liver cirrhosis, and complex infectious liver diseases. Led by Dr. Wei Lai (魏来), a nationally recognized hepatologist and infectious disease specialist, the department offers international patients access to the latest antiviral therapies for hepatitis B and C, comprehensive cirrhosis management, and seamless integration with Ruijin Hospital's Liver Surgery team for patients whose liver disease has progressed to hepatocellular carcinoma. China has one of the world's highest burdens of hepatitis B and liver cancer, and Ruijin Hospital's hepatology team has unparalleled experience managing the full spectrum of HBV-related liver disease — from early chronic hepatitis to decompensated cirrhosis and HCC.
What Conditions Are Treated?
Ruijin Hospital's Hepatology and Infectious Disease Department specializes in the diagnosis and management of:
- Chronic hepatitis B (CHB) — including treatment-naive, treatment-experienced, and drug-resistant cases
- Chronic hepatitis C (CHC) — including all genotypes, using direct-acting antiviral (DAA) therapy
- Liver cirrhosis — compensated and decompensated, including management of ascites, varices, and hepatic encephalopathy
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Autoimmune hepatitis (AIH)
- Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)
- Drug-induced liver injury (DILI)
- Hepatitis B reactivation in patients on immunosuppressive therapy or chemotherapy
- Liver disease in the context of HIV co-infection
- Surveillance and early detection of hepatocellular carcinoma (HCC) in high-risk patients
Why International Patients Choose Ruijin for Hepatology
International patients choose Ruijin Hospital's Hepatology Department for its exceptional expertise in hepatitis B — the most common cause of liver cancer globally — and its access to the full range of approved antiviral therapies including tenofovir alafenamide (TAF), entecavir, and novel agents in clinical trials. For patients with hepatitis C who have failed prior treatment or have complex genotypes, Ruijin's access to pan-genotypic DAA regimens ensures high cure rates even in difficult cases. For patients with cirrhosis who need expert management of complications — including variceal bleeding, ascites, and hepatic encephalopathy — the department's close collaboration with Liver Surgery and Interventional Radiology ensures seamless escalation of care when needed. For patients at high risk of liver cancer due to cirrhosis or chronic HBV, Ruijin's structured surveillance program provides the earliest possible detection.
How CMCS Arranges Your Appointment
CMCS manages every aspect of your medical visit so you can focus on your health. Here's how we help:
- Initial Consultation: Contact CMCS and share your liver function tests, hepatitis serology, viral load results, and liver imaging.
- Case Review: Our team reviews your case and confirms the most appropriate hepatologist within Dr. Wei's department.
- Appointment Booking: We coordinate directly with Ruijin Hospital to secure your consultation at a convenient time.
- Pre-Visit Preparation: We advise on which blood tests, imaging, and prior treatment records to bring or arrange in advance.
- On-the-Day Support: A CMCS coordinator accompanies you through registration, consultation, and any same-day blood tests or liver assessments.
- Follow-Up & Treatment Coordination: We help you understand your diagnosis and treatment plan, and coordinate any follow-up antiviral therapy, liver surveillance, or specialist referrals needed.
What to Prepare Before Your Visit
To ensure the most productive hepatology consultation, please prepare:
- Liver function tests: ALT, AST, GGT, bilirubin, albumin, INR/PT
- Hepatitis B serology: HBsAg, HBeAg, anti-HBe, anti-HBs, HBV DNA viral load
- Hepatitis C serology: anti-HCV, HCV RNA viral load, HCV genotype
- Liver fibrosis assessment: FibroScan (elastography) report, or APRI/FIB-4 scores
- Liver imaging: ultrasound, CT or MRI (for cirrhosis and HCC surveillance)
- AFP tumor marker (for HCC surveillance)
- Records of all prior antiviral treatments and response assessments
- A full list of current medications
- Your passport and travel/health insurance documents
What to Expect on the Day
Ruijin Hospital's Hepatology Department is equipped with comprehensive liver function testing, FibroScan elastography, liver biopsy facilities, and a structured HCC surveillance program. Your consultation will involve a thorough review of your hepatitis serology, viral load, liver function, and imaging data, followed by a clear discussion of antiviral treatment options and liver disease management. CMCS will ensure all communication is clear and that you leave with a complete understanding of your liver condition and the recommended plan. If your liver disease has progressed to cirrhosis complications or liver cancer, we can coordinate referrals to Liver Surgery or Interventional Radiology within Ruijin Hospital seamlessly.
Contact CMCS to Get Started
Ready to book your hepatology consultation at Ruijin Hospital? Contact our team today:
CMCS is your trusted medical concierge partner in Shanghai — making world-class Chinese healthcare accessible to international patients.
0件のコメント